Cosciens closes second tranche of convertible debenture offering
Cosciens Biopharma says it has closed the second tranche of a non-brokered private placement of 15% unsecured convertible debentures, further to its Sept. 10, 2026 press release.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.